CYIL vol. 16 (2025)

VLADIMÍRA TĚŠITELOVÁ Conclusion

If we are to answer the question posed in the title of this article (i.e. whether data in clinical genetics are sufficiently protected), the answer is – in the author’s opinion – yes, from a general legislative point of view. Czech legislation corresponds in principle to the standard of protection enshrined in the relevant international treaties and in European law. However, if we ask another question, i.e. whether specific legislation for the use of AI tools in healthcare would be appropriate, in the author’s opinion it would be advisable to anchor it, at least in the areas related to informed consent to the provision of health services or liability for the use of AI tools.

392